BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, May 8, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 8, 2009
View Archived Issues
Durasphere bulking agent effective for recurrent pyelonephritis in kidney transplant patients
Read More
Duquesne University discloses novel tricyclic compounds for cancer treatment
Read More
New heterocyclic compounds in early development at AstraZeneca for the treatment of cancer
Read More
Shanghai Hengrui describes new protein kinase inhibitors in early development
Read More
GSK researchers describe new histamine H3 receptor antagonists for cognitive impairment
Read More
Merck & Co. claims new guanylate cyclase activators for the treatment of hypertension
Read More
Siga presents novel antiviral drugs active against hemorrhagic fever viruses
Read More
Exenatide induces weight loss and glucose normalization in nondiabetic obese patients
Read More
Alseres receives SPA agreement from FDA for phase III Altropane trial
Read More
Intercell initiates phase I Streptococcus pneumoniae vaccine trial
Read More
Seattle Genetics enters antibody-drug conjugate collaboration with Millennium
Read More
Positive phase II findings for Reolysin with radiation in advanced cancers
Read More
Watson launches Rapaflo
Read More
Novel JAK1/JAK2 inhibitor developed by Cytopia for the treatment of myeloproliferative disorders
Read More
Danisco BioActives and Sigma-Tau collaborate on necrotizing enterocolitis drug
Read More
Serentis starts phase II first-in-class SRD-441 study for eczema
Read More
FDA accepts Theravance's telavancin NDA for hospital-acquired pneumonia
Read More
Genta completes patient enrollment in global phase III Genasense trial
Read More
Health Canada approves once-daily Prezista as part of combination HIV therapy
Read More
TRITON-TIMI 38 data on prasugrel in acute coronary syndromes further analyzed
Read More
Aplenzin extended-release tablets available in the U.S.
Read More
Cardiovascular risk with PPAR agonist aleglitazar assessed in diabetes patients
Read More
FDA Advisory Committee provides opinion on Serdolect in schizophrenia
Read More
Daiichi Sankyo and Eli Lilly launch Efient in the U.K.
Read More
